Lacosamide Adroiq Europska Unija - hrvatski - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakozamida - epilepsija - antiepileptici sredstva, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakozamida - epilepsija - antiepileptici sredstva, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide UCB Europska Unija - hrvatski - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakozamida - epilepsije, djelomično - antiepileptici sredstva, - proizvođač УКБ prikazan kao monoterapija i dodatna terapija u liječenju parcijalnih napadaja napad sa ili bez sekundarne generalizacije kod odrasle, mlade i djecu od 4 godine s epilepsijom.

Etoposide Sandoz 20 mg/ml koncentrat za otopinu za infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

etoposide sandoz 20 mg/ml koncentrat za otopinu za infuziju

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - etopozid - koncentrat za otopinu za infuziju - 20 mg/ml - urbroj: 1 ml koncentrata za otopinu za infuziju sadrži 20 mg etopozida

Spravato Europska Unija - hrvatski - EMA (European Medicines Agency)

spravato

janssen-cilag international nv - esketamine hidroklorid - depresivni poremećaj - ostali antidepresivi - spravato, u kombinaciji sa ssri ili СИОЗН je za odrasle osobe s otporan na terapiju depresivnih poremećaja, koji se nisu odazvali, barem dvije različite metode liječenja antidepresivima u ovom umjerene i teške depresivne epizode.